Skip to main content
. 2022 Jul 17;23(14):7891. doi: 10.3390/ijms23147891

Figure 3.

Figure 3

The effect of co-administration of low-dose cannabidiol (CBD) and myrcene on joint pain and inflammation. While low-dose myrcene reduced hindlimb pain (A) and leukocyte rolling (B), the addition of cannabidiol (CBD) had no additional effect on these analgesic or anti-inflammatory responses. ns—not significant, *** p < 0.001, one-factor RMANOVA with Bonferroni’s post hoc test. Data are means ± S.E.M.